Spots Global Cancer Trial Database for Safety and Efficacy of Oncoxin in Hepatocellular Carcinoma (HCC)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Safety and Efficacy of Oncoxin in Hepatocellular Carcinoma (HCC)
Official Title: Study to Evaluate Safety and Therapeutic Efficacy of a Nutritional Supplement 'Oncoxin' in Patients With Hepatocellular Carcinoma
Study ID: NCT01392131
Conditions
Study Description
Brief Summary: Oncoxin is safe and results in improved survival in patients with hepatocellular carcinoma
Detailed Description: To assess therapeutic efficacy and safety of Oncoxin in hepatocellular carcinoma To see if there is reduction in serum alpha fetoprotein level in hepatocellular carcinoma patients after administration of Oncoxin To see if there is reduction tumor size and or number in hepatocellular carcinoma patients after administration of Oncoxin To see if there is improvement of quality of life in hepatocellular carcinoma patients after administration of Oncoxin To see if there is improved survival in hepatocellular carcinoma patients after administration of oncoxin
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Farabi General Hospital, Dhaka, , Bangladesh
Contact Details
Name: Mamun A Mahtab, MSc MD FACG
Affiliation: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
